In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Amneal Pharmaceuticals, Inc.

http://www.amneal.com

Latest From Amneal Pharmaceuticals, Inc.

Amneal Says Vertical Integration Will Be Key To Compete In Biosimilars

Stressing the need for vertical integration to be a successful biosimilars developer in the long run, Amneal co-CEO Chirag Patel has set out the firm’s future strategy in the area – including aiming to be quicker to market with future launches – as Amneal proves itself against rival biosimilars players in the US market.

Biosimilars Strategy

Amneal CEO: Changes At Teva, Sandoz And Viatris Give Us Room To Grow

Amid upheaval for leading industry players Sandoz, Teva and Viatris, Amneal sees room to grow both in its home market and internationally, according to co-CEO Chirag Patel.

Strategy Generic Drugs

Differentiation Is Mantra As Amneal Targets $1bn By 2030 From Non-US Geographies

As Amneal makes its commercial debut in markets outside the US, Shyamakant Giri, MD and president, India and emerging markets, formulates a strategy based on differentiation and a targeted approach. From ‘theranostics’ to partnered products, he has multiple aces up his sleeves, Giri tells Scrip in an interview.

Commercial Leadership

Amneal Reveals Orion As European Partner

Amneal has delivered on promises that it would soon finalize a European partnership by announcing a long-term licensing collaboration with Finnish firm Orion that will also cover Australia and New Zealand.

Deals Strategy
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • Specialty Pharmaceuticals
  • Other Names / Subsidiaries
    • Amedra Pharmaceuticals LLC
    • Amneal Pharmaceuticals, LLC
    • CorePharma LLC
    • Gemini Laboratories, LLC
    • Impax Generics
    • Impax Laboratories, Inc. (IPXL)
    • Impax Specialty Pharma
    • Lineage Therapeutics Inc.
    • Tower Holdings, Inc.
UsernamePublicRestriction

Register